132 related articles for article (PubMed ID: 4582845)
1. Cefazolin therapy of urinary tract infections.
Cox CE
J Infect Dis; 1973 Oct; 128():Suppl:S397-8. PubMed ID: 4582845
[No Abstract] [Full Text] [Related]
2. Cefazolin in the treatment of bacterial pneumonia.
Turck M; Clark RA; Beaty HN; Holmes KK; Karney WW; Reller LB
J Infect Dis; 1973 Oct; 128():Suppl:S382-5. PubMed ID: 4147579
[No Abstract] [Full Text] [Related]
3. Treatment of cefazolin in 45 cases of urinary tract infections.
Lus RG; Calvo MC; Lopez LG; Cancer RC; Molina AM; Sanchez ED; Parilla AC; Mur LL
Chemotherapy; 1977; 23(2):106-113. PubMed ID: 318980
[TBL] [Abstract][Full Text] [Related]
4. Cefazolin in the treatment of uncomplicated gonorrhea in men.
Nelson M
J Infect Dis; 1973 Oct; 128():Suppl:S404-6. PubMed ID: 4200655
[No Abstract] [Full Text] [Related]
5. Therapy of infections with cefazolin.
Schreiner A; Digranes A; Hamre E; Nygaard H
Chemotherapy; 1976; 22(6):381-9. PubMed ID: 821726
[TBL] [Abstract][Full Text] [Related]
6. Clinical and laboratory evaluation of cefazolin: a new cephalosporin antibiotic in pediatric patients.
Khan AJ
Curr Ther Res Clin Exp; 1973 Oct; 15(10):727-33. PubMed ID: 4201317
[No Abstract] [Full Text] [Related]
7. Evaluation of cefazolin in the treatment of bacterial endocarditis and bacteremia.
Reinarz JA; Kier CM; Guckian JC
J Infect Dis; 1973 Oct; 128():Suppl:S392-6. PubMed ID: 4147580
[No Abstract] [Full Text] [Related]
8. [Cefazolin. 3. Double blind controlled trial in urinary tract infections].
Seika K; Minakawa M; Miyoshi K; Yamaji K; Sugiyama Y
Jpn J Antibiot; 1972 Apr; 25(2):72-8. PubMed ID: 4627212
[No Abstract] [Full Text] [Related]
9. [Clinical experience with cefazolin(CEZ) for bile-duct infections (author's transl)].
Shimura H; Hisatsugu T; Furusawa T; Imaizumi N; Yamamoto Y
Jpn J Antibiot; 1974 Feb; 27(1):27-31. PubMed ID: 4546320
[No Abstract] [Full Text] [Related]
10. Clinical and pharmacologic evaluation of cefazolin in children.
Pickering LK; O'Connor DM; Anderson D; Bairan AC; Feigin RD; Cherry JD
J Infect Dis; 1973 Oct; 128():Suppl:S407-1. PubMed ID: 4744023
[No Abstract] [Full Text] [Related]
11. Antibacterial activity and pharmacokinetic behavior of cefazolin as compared with five other cephalosporin antibiotics.
Naumann P; Reintjens E
Infection; 1974; 2(1):19-24. PubMed ID: 4598259
[No Abstract] [Full Text] [Related]
12. Cephacetrile, a new cephalosporin, in the treatment of urinary tract infections.
Wise R; Reeves DS; Hepburn PR
Chemotherapy; 1974; 20(3):177-82. PubMed ID: 4211859
[No Abstract] [Full Text] [Related]
13. Clinical experiences with cefazolin and other cephalosporins in bacterial endocarditis.
Quinn EL; Pohlod D; Madhavan T; Burch K; Fisher E; Cox F
J Infect Dis; 1973 Oct; 128():Suppl:S386-9. PubMed ID: 4744022
[No Abstract] [Full Text] [Related]
14. Treatment of gonorrhea with cefazolin plus probenecid.
Duncan WC
J Infect Dis; 1974 Oct; 130(4):398-401. PubMed ID: 4216610
[No Abstract] [Full Text] [Related]
15. Comparative evaluation of cefazolin and cephalothin in children.
Pickering LK; O'Connor DM; Anderson D; Bairan AC; Feigin RD; Cherry JD
J Pediatr; 1974 Dec; 85(6):842-7. PubMed ID: 4417819
[No Abstract] [Full Text] [Related]
16. A five-step approach to antimicrobial medication. 2. Urinary tract infections.
Parker RH; Fossieck BE
Geriatrics; 1974 Dec; 29(12):75-83. PubMed ID: 4372129
[No Abstract] [Full Text] [Related]
17. Cefazolin in the treatment of gonorrhea.
Karney WW; Turck M; Holmes KK
J Infect Dis; 1973 Oct; 128():Suppl:S399-4. PubMed ID: 4200654
[No Abstract] [Full Text] [Related]
18. Evaluation of cefazolin as a surrogate marker for cefpodoxime susceptibility for urinary tract isolates.
Bookstaver DA; Bland CM; Arroyo MA
J Med Microbiol; 2015 Oct; 64(10):1170-1173. PubMed ID: 26219948
[TBL] [Abstract][Full Text] [Related]
19. The bacteriology of urinary-tract infection.
Grüneberg RN
Practitioner; 1972 Apr; 208(246):551-3. PubMed ID: 4624154
[No Abstract] [Full Text] [Related]
20. [Urinary tract infection in infants (376 cases) in a Moroccan hospital (2009-2010)--etiologic frequency and prevalence of resistance].
Arsalane L; Zouhair S; Lahlou Amine I; Louzi L; Bouskraoui M
Pathol Biol (Paris); 2012 Dec; 60(6):e90-1. PubMed ID: 23123108
[No Abstract] [Full Text] [Related]
[Next] [New Search]
